Trends in immunology
Cure8 research brief
Why This Matters
This review explains mechanisms by which gut inflammation can reprogram bone marrow and innate immunity, a process that may help explain persistent inflammation and risks like colitis-associated cancer. Understanding these pathways could guide future therapies or biomarkers relevant to people with IBD.
Who Should Pay Attention
Researchers studying IBD immunology, clinicians interested in disease mechanisms and translational research, and patients curious about emerging biological explanations for persistent inflammation and cancer risk.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The review synthesizes studies linking gut inflammation to long-lived changes in innate immune cells produced by the bone marrow (emergency granulopoiesis) and how those cells feed back to worsen or maintain intestinal disease. It highlights physiological regulatory nodes between gut and marrow and notes translational implications for future therapies.
The piece does not report original trial results; it summarizes current mechanistic and translational literature. Readers should not interpret this as new clinical evidence for a specific treatment or diagnostic change.
Instead the article frames research directions (immune-pathway targets, biomarkers, host–microbiome interactions) that could inform future therapies or risk stratification.
Keep In Mind
Structured content depth: abstract — this classification and note are based on the PubMed abstract (a review article). The article summarizes existing research rather than presenting new clinical trial results; it should be interpreted as mechanistic and translational context rather than direct clinical guidance.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationTrends in immunology
AuthorsSílvia Pires, Randy S Longman
InstitutionDepartment of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA; Jill Roberts Center for Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA; Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.
Study typeJournal article, review
Indexed viaPubMed
Source typeResearch paper
PublishedAug 5, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of interests R.S.L. is a consultant for Pfizer, Merck, Sanofi, Xencor, Spyre, Shattuck, Vedanta, SAB member for CJ Biosciences and Ancilia Biosciences, and grant recipient from Boehringer Ingelheim.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Towards a basis for vascular versus intestinal phenotype differences; East Meets West in Behcet's disease.
Identifies genetic and immune-pathway differences that may explain why Behçet's disease shows more intestinal involvement in some populations—insight that could inform research into IBD-like gut inflammation and future...
XANTHINE OXIDOREDUCTASE IN DIGESTIVE DISEASES: A CONTEXT-DEPENDENT REDOX SWITCH LINKING INFLAMMATION, METABOLISM AND CARCINOGENESIS.
XOR is linked to oxidative stress, inflammation, drug (thiopurine) metabolism, microbiome interactions, and inflammation-associated colorectal cancer — all processes relevant to IBD pathogenesis and complications....
Host-microbe Interactions in the Appendix of Children with Inflammatory Bowel Diseases.
Researchers found distinct microbial and host molecular features in the appendices of children with IBD, which could help explain local immune activation and guide future studies of disease mechanisms or biomarkers.